LILLIAN SUDDUTH: Open Payments
NPI 1356961932 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 23 payments from 9 companies in 2025. Trend: 2023 $1,302 · 2024 $1,207 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $137 |
| Alkermes, Inc. | 4 | $69 |
| Janssen Pharmaceuticals, Inc | 3 | $44 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Lundbeck LLC | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| ABBVIE INC. | 1 | $14 |
| Corium, LLC | 3 | $10 |
Products named: COBENFY, ARISTADA, SPRAVATO, FANAPT, ABILIFY MAINTENA, INGREZZA, UZEDY, VRAYLAR.
Industry payments across AL — which companies pay providers there.
